Journal
BIOMATERIALS
Volume 101, Issue -, Pages 189-198Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2016.05.050
Keywords
Antibody response; Antigen density; Glycopolymer; Tumor associated carbohydrate antigen; Valency
Funding
- National Cancer Institute [R01CA149451, R03AI111054]
- American Cancer Society [RSG-12-170-01-LIB]
Ask authors/readers for more resources
For successful carbohydrate based anti-cancer vaccines, it is critical that B cells are activated to secret antibodies targeting the tumor associated carbohydrate antigens (TACAs). Despite the availability of many TACA based constructs, systematic understanding of the effects of structural features on anti-glycan antibody responses is lacking. In this study, a series of defined synthetic glyco-polymers bearing a representative TACA, i.e., the Thomsen-nouveau (Tn) antigen, have been prepared to probe the induction of early B cell activation and antibody production via a T cell independent mechanism. Valency and density of the antigen in the polymers turned out to be critical. An average of greater than 6 Tn per chain was needed to induce antibody production. Glycopolymers with 40 antigens per chain and backbone molecular weight of 450 kDa gave the strongest stimulation to B cells in vitro, which correlated well with its in vivo activity. Deviations from the desired valency and density led to decreased antibody production or even antigen specific B cell non-responsiveness. These findings provide important insights on how to modulate anti-TACA immune responses facilitating the development of TACA based anticancer vaccines using glycopolymers. (C) 2016 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available